Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

202 9 Dendritic Cells and Cancer: Prospects for Cancer Vaccination
Levy R. Biol Blood Marrow Transplant
2000; 6: 621±627.
141 Thurner B, Haendle I, Roder C,
Dieckmann D, Keikavoussi P, Jonuleit
H, Bender A, Maczek C, Schreiner
D, von den Driesch P,
Brocker EB, Steinman RM, Enk A,
Kampgen E, Schuler G. J Exp Med
1999; 190: 1669±1678.
142 Toungouz M, Libin M, Bulte F,
Faid L, Lehmann F, Duriau D, Laporte
M, Gangji D, Bruyns C, Lambermont
M, Goldman M,Velu T.
J Leuk Biol 2001; 69: 937±943.
143 Lau R,Wang F, Jeffery G, Marty V,
Kuniyoshi J, Bade E, Ryback ME, Weber
J. J Immunother 2001; 24: 66±78.
144 Jonuleit H, Giesecke-Tuettenberg A,
Tuting T, T hurner-Schuler B,
Stuge TB, Paragnik L, Kandemir A,
Lee PP, Schuler G, Knop J, Enk AH.
Int J Cancer 2001; 93: 243±251.
145 Rieser C, Ramoner R, Holtl L, Rogatsch
H, Papesh C, Stenzl A,
Bartsch G, Thurnher M. Urol Int
2000; 63: 151±159.
146 Holtl L, Rieser C, Papesh C, Ramoner
R, Herold M, Klocker H, Radmayr
C, Stenzl A, Bartsch G, Thurnher
M. J Urol 1999; 161: 777±782.
147 Thurnher M, Rieser C, Holtl L, Papesh
C, Ramoner R, Bartsch G. Urol
Int 1998; 61: 67±71.
148 Murphy G,Tjoa B, Ragde H, Kenny G,
Boynton A. Prostate 1996; 29: 371±380.
149 Murphy GP, Tjoa BA, Simmons SJ,
Ragde H, Rogers M, Elgamal A,
Kenny GM, Troychak MJ, Salgaller
ML, Boynton AL. Prostate 1999;
39: 54±59.
150 Murphy GP, Tjoa BA, Simmons SJ,
Jarisch J, Bowes VA, Ragde H, Rogers
M, Elganal A, Kenny GM,
Cobb OE, Ireton RC, Troychak MJ,
Salgaller ML, Boynton AL. Prostate
1999; 38: 73±78.
151 Lodge PA, Jones LA, Bader RA, Murphy
GP, Salgaller ML. Cancer Res
2000; 60: 829±833.
152 Murphy GP, Snow P, Simmons SJ,
Tjoa BA, Rogers MK, Brandt J,
Healy CG, Bolton WE, Rodbold D.
Prostate 2000; 42: 67±72.
153 Tjoa BA, Murphy GP. Immunol Lett
2000; 74: 87±93.
154 Tjoa BA, Simmons SJ, Bowes VA,
Ragde H, Rogers M, Elgamal A,
Kenny GM, Cobb OE, Ireton RC,
Troychak MJ, Salgaller ML, Boynton
AL, Murphy GP. Prostate 1998; 36:
39±44.
155 Tjoa BA, Simmons SJ, Elgamal A, Rogers
M, Ragde H, Kenny GM, Troychak
MJ, Boynton AL, Murphy GP.
Prostate 1999; 40: 125±129.
156 Salgaller ML, Lodge PA, McLean JG,
Tjoa BA, Loftus DJ, Ragde H,
Kenny GM, Rogers M, Boynton AL,
Murphy GP. Prostate 1998; 35: 144±
151.
157 Burch PA, Breen JK, Buckner JC,
Gastineau DA, Kaur JA, Laus RL,
Padley DJ, Peshwa MV, Pitot HC, Richardson
RL, Smits BJ, Sopapan P,
Strang G,Valone FH,Vuk-Pavlovic S.
Clin Cancer Res 2000; 6: 2175±2182.
158 Morse M, Deng Y, Coleman D,
Hull S, Kitrell-Fisher E, Nair S,
Schlom J, Ryback M, Lyerly H. Clin
Cancer Res 1999; 5: 1331±1338.
159 Brossart P,Wirths S, Stuhler G,
Reichardt VL, Kanz L, Brugger W.
Blood 2000; 96: 3102±3108.
160 Kobayashi T, Shinohara H,Toyoda M,
Iwamoto S, Tanigawa N. Surg Today
2001; 31: 513±516.
161 Fujii S, Shimizu K, Fujimoto K, Kiyokawa
T, Shimomura T, Kinoshita M,
Kawano F. Jpn J Cancer Res 1999; 90:
1117±1129.
162 Geiger J, Hutchinson R, Hohenkirk
L, McKenna E, Chang A, Mule J.
Lancet 2000; 356: 1163±1165.
163 Yu JS,Wheeler CJ, Zeltzer PM,
Ying H, Finger DN, Lee PK,
Yong WH, Incardona F, Thompson
RC, Riedinger MS, Zhang W,
Prins RM, Black KL. Cancer Res 2001;
61: 842±847.
164 Kikuchi T, Akasaki Y, Irie M,
Homma S, Abe T, Ohno T. Cancer Immunol
Immunother 2001; 50: 337±344.
165 Mackensen A, Drager R, Schlesier
M, Mertelsmann R, Lindemann
A. Cancer Immunol Immunother
2000; 49: 152±156.